Gabriella Pieri
Overview
Explore the profile of Gabriella Pieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study
Santoleri F, Abrate P, Pestrin L, Pasut E, Modesti G, Musicco F, et al.
Glob Reg Health Technol Assess
. 2024 Oct;
11:191-199.
PMID: 39397811
Introduction: This study aims to evaluate the persistence, treatment adherence and drug cost associated with biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in the management of psoriatic arthritis (PsA)...
2.
Santoleri F, Musicco F, Fulgenzio C, Abrate P, Pestrin L, Pasut E, et al.
Immunotherapy
. 2024 Apr;
16(9):611-621.
PMID: 38651935
This study aims to investigate drug utilization patterns in the treatment of psoriasis (PsO) from 1 to 5 years in a real-life setting with Adalimumab (Ada), Etanercept (Eta), Ustekinumab (Ust),...
3.
Starace E, de Pasquale G, Morenghi E, Crippa C, Matteucci S, Pieri G, et al.
Nutrients
. 2023 Dec;
15(24).
PMID: 38140320
Hospital malnutrition is especially common among elderly patients with neurological deficits or dementia. These conditions can be exacerbated by unpalatable diets and issues such as dysphagia and presbyphagia. Our study...
4.
Crippa C, Matteucci S, Pastore M, Morenghi E, Starace E, de Pasquale G, et al.
Nutrients
. 2023 Nov;
15(22).
PMID: 38004125
The prevalence of malnutrition is increasing globally due to factors such as age-related pathological conditions and diseases that impact food and beverage intake. In hospital settings, older adult patients often...
5.
Santoleri F, Lasala R, Abrate P, Pestrin L, Pasut E, Modesti G, et al.
Curr Med Res Opin
. 2023 Nov;
39(12):1729-1735.
PMID: 37994874
Objectives: The objective was to assess the adherence, persistence, and costs of bDMARDs through a multicentre study of nine Italian hospital pharmacies. Methods: The drugs analysed were Abatacept, Adalimumab, Certolizumab,...
6.
Bramanti S, De Philippis C, Bartoli A, Giordano L, Mariotti J, Sarina B, et al.
Transplant Cell Ther
. 2021 Aug;
27(11):912.e1-912.e6.
PMID: 34403790
Busulfan (Bu) is an alkylating agent routinely used for conditioning regimens before allogeneic stem cell transplantation (allo-SCT). Bu shows wide pharmacokinetic (PK) variability among patients. Patients can have a higher...
7.
Malipiero G, Paoletti G, Puggioni F, Racca F, Ferri S, Marsala A, et al.
J Allergy Clin Immunol
. 2020 Apr;
146(1):227.
PMID: 32317114
No abstract available.